PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ARTIFICIAL ONCOLYTIC VIRUSES AND RELATED METHODS

Application WO-2021211902-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.